Published in Blood Weekly, October 27th, 2005
Revivicor will work with Zimmer's Biologics group to adapt its proprietary genetic engineering technology for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.